The purpose of this study is to evaluate the rate of "add-on" solifenacin treatment and its persistency in men with over active bladder symptoms after tamsulosin monotherapy for 4 weeks.
This is a multi-center study to evaluate the efficacy, safety, and persistency of solifenacin treatment in male patients with persistent OAB symptoms of urinary frequency and urgency with/without urgency incontinence who are receiving tamsulosin monotherapy for LUTS at a stable dose for 4 weeks in real life practice. Also proportion of patients and predictive factors with persistent OAB symptoms after tamsulosin monotherapy will be investigated.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
307
Oral
Unnamed facility
Cheonju, South Korea
Unnamed facility
Choongju, South Korea
Unnamed facility
Daegu, South Korea
Unnamed facility
Daejeon, South Korea
Percentage of patients with "add-on" solifenacin treatment
Time frame: Weeks of 12, 24 and 52 of combination therapy
Change from baseline in micturition efficacy parameters
Time frame: Weeks of 12, 24 and 52 of combination therapy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Kangneung, South Korea
Unnamed facility
Kwangju, South Korea
Unnamed facility
Pusan, South Korea
Unnamed facility
Seoul, South Korea
Unnamed facility
Suwon, South Korea